logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Revue Neurologique cover

Revue Neurologique

IF2.3
Papers243
Citations3521
Journal Papers 247
Publication Date
delete
Beyond migraine: A narrative review of photophobia's clinical spectrum
deleteRevue Neurologique
IF2.3
delete2026-07-09
delete0
deleteOAAI
deleteD. Doukhi; C. Vignal; J. Mawet
deleteShare
deleteSave
Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study
deleteRevue Neurologique
IF2.3
delete2026-07-03
delete0
deleteOAAI
deleteR. Demeret; D. Vieles Marais; E. Treiner; B. Acket; V. Fabry; T. Levade; L. Nogueira; J.-C. Pages; P. Cintas
deleteShare
deleteSave
Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry
deleteRevue Neurologique
IF2.3
delete2026-06-29
delete0
PREAI
deleteC. Maisonnier; J.-P. Cottier; G. Charbonnier; A. Monaya; J. Rhein; M. Gaudron; M. Haba; N. Deschamps; A. Nasri; B. de Toffol; I.L. Maldonado
deleteShare
deleteSave
Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?
deleteRevue Neurologique
IF2.3
delete2026-06-17
delete0
PREAI
deleteA. Marques; C. Lambert; P. Derost; C. Beal; B. Debilly; I. Rieu; F. Durif
deleteShare
deleteSave
Neuro-Whipple presenting as autoimmune encephalitis
deleteRevue Neurologique
IF2.3
delete2026-06-15
delete0
PREAI
deleteR. Assaraj; I. Al Chare; C. Marois; C. Bousquet-Mélou; V. Pourcher; B. Degos
deleteShare
deleteSave
Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families
deleteRevue Neurologique
IF2.3
delete2026-06-03
delete0
PREAI
deleteH. Gharebaghian; M. Ravanbod; A. Ghasemi; A. Asghar Okhovat; S. Nafissi; A. Alavi
deleteShare
deleteSave
Current management and treatment of patients with myasthenia gravis in France: A survey of the neurologist's perspective
deleteRevue Neurologique
IF2.3
delete2026-06-03
delete0
PREAI
deleteP. Cintas; E. Salort-Campana; S. Demeret; T. Stanbury; B. Bouquillon; A. Nadaj-Pakleza; J. Gallard; G. Solé; S. Attarian
deleteShare
deleteSave
Ambulatory introduction of foslevodopa/foscarbidopa in Parkinson's disease in private practice. Case series of the first 22 patients
deleteRevue Neurologique
IF2.3
delete2026-06-01
delete0
PREAI
deleteC. Bonnet; V. Mesnage; F. Sacko; C. Ziz; P. Jaulent
deleteShare
deleteSave
Six-month outcomes of subcutaneous foslevodopa/foscarbidopa according to initiation setting in advanced Parkinson's disease: A retrospective cohort study
deleteRevue Neurologique
IF2.3
delete2026-05-27
delete0
PREAI
deleteC. Desjardins; H. de Saint Vaulry; C. Rosset; Q. Salardaine; J.-P. Brandel; G. Baille
deleteShare
deleteSave
Real-world utilization of acute treatments for cluster headache: Insights from the French National Open Health Data
deleteRevue Neurologique
IF2.3
delete2026-05-22
delete0
deleteOAAI
deleteV. Arcani; A. Bruyat; G. Hache; A. Donnet; S. Redon
deleteShare
deleteSave
Establishing age-stratified reference values for blood Neurofilament Light chain (NfL) using the Lumipulse® platform
deleteRevue Neurologique
IF2.3
delete2026-05-21
delete0
PREAI
deleteA. Hanin; S. Bahroun; V. Chiodega; D. Bonnefont-Rousselot; M. Del Mar Amador; F. Salachas; S. Mariotto; G. Dingeo; L. Foudil
deleteShare
deleteSave
Primary Lateral Sclerosis French National Diagnostic and Care Protocol
deleteRevue Neurologique
IF2.3
delete2026-05-21
delete0
deleteOAAI
deleteP. Corcia; E. Bernard; E. de la Cruz; V. Danel; M.-H. Soriani; N. Guy; F. Esselin; G. Bruneteau; P.-F. Pradat; V. Goutines; J. Catherine; N. Eyraud; P. Cheve; A. Fernandez; D. Erazo; P. Couratier
deleteShare
deleteSave
Level of consciousness, wakefulness and responsiveness in epileptic seizures
deleteRevue Neurologique
IF2.3
delete2026-05-15
delete0
PREAI
deleteS. Beniczky; P. Ryvlin; P. Kahane; E. Trinka
deleteShare
deleteSave
New tools to shape the future of MS and related disorders
deleteRevue Neurologique
IF2.3
delete2026-05-12
delete0
PREAI
deleteC. Louapre
deleteShare
deleteSave
7T magnetic resonance imaging of the human spinal cord in multiple sclerosis: Advances, insights and unmet needs
deleteRevue Neurologique
IF2.3
delete2026-04-23
delete0
deleteOAAI
deleteV. Callot; A. Destruel; S. Demortière; B. Testud
deleteShare
deleteSave
The role of Epstein-Barr virus in multiple sclerosis: From pathogenesis to therapeutic potential
deleteRevue Neurologique
IF2.3
delete2026-04-22
delete0
deleteOAAI
deleteG. Bellucci; R. Mechelli; R. Bigi; G. Ristori; M. Salvetti
deleteShare
deleteSave
New immunotherapies for multiple sclerosis (MS): A comprehensive review
deleteRevue Neurologique
IF2.3
delete2026-04-20
delete0
PREAI
deleteX. Ayrignac
deleteShare
deleteSave
Treatment pathway, healthcare resource utilization and direct cost of ALS in France: A nationwide claims database study
deleteRevue Neurologique
IF2.3
delete2026-04-17
delete0
PREAI
deleteC. Desnuelle; P. Couratier; P. Corcia; A. Duburcq; E. Torreton; S. Baffert; C. Nevoret; S. Turgeman
deleteShare
deleteSave
Cell therapy in multiple sclerosis: An overview
deleteRevue Neurologique
IF2.3
delete2026-04-16
delete0
deleteOAAI
deleteL. Michel
deleteShare
deleteSave
Imaging myelin content changes: A bridge between tissue and clinics
deleteRevue Neurologique
IF2.3
delete2026-04-14
delete0
deleteOAAI
deleteR. Galbusera; C. Stadelmann; C. Granziera
deleteShare
deleteSave